81 related articles for article (PubMed ID: 31929675)
1. Noninvasive imaging of dual-agent uptake in glioma and normal tissue using MRI-coupled fluorescence tomography.
Meng B; Folaron MR; Strawbridge RR; Sadeghipour N; Samkoe KS; Tichauer K; Davis SC
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10874():. PubMed ID: 31929675
[TBL] [Abstract][Full Text] [Related]
2. Estimating drug delivery using hybrid system for simultaneous dynamic MRI and fluorescence tomography.
Meng B; Folaron MR; Strawbridge RR; Samkoe KS; Tichauer K; Davis SC
Proc SPIE Int Soc Opt Eng; 2020; 11219():. PubMed ID: 34707326
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive quantification of target availability during therapy using paired-agent fluorescence tomography.
Meng B; Folaron MR; Strawbridge RR; Sadeghipour N; Samkoe KS; Tichauer K; Davis SC
Theranostics; 2020; 10(24):11230-11243. PubMed ID: 33042280
[TBL] [Abstract][Full Text] [Related]
4. Examining the Feasibility of Quantifying Receptor Availability Using Cross-Modality Paired-Agent Imaging.
Meng B; Sadeghipour N; Folaron MR; Strawbridge RR; Samkoe KS; Tichauer KM; Davis SC
Mol Imaging Biol; 2022 Feb; 24(1):23-30. PubMed ID: 34286423
[TBL] [Abstract][Full Text] [Related]
5. Estimating paired-agent uptake in altered tumor vasculature using MRI-coupled fluorescence tomography.
Meng B; Strawbridge RR; Tichauer K; Samkoe KS; Davis SC
Proc SPIE Int Soc Opt Eng; 2020; 11216():. PubMed ID: 34446978
[TBL] [Abstract][Full Text] [Related]
6. Dynamic dual-tracer MRI-guided fluorescence tomography to quantify receptor density in vivo.
Davis SC; Samkoe KS; Tichauer KM; Sexton KJ; Gunn JR; Deharvengt SJ; Hasan T; Pogue BW
Proc Natl Acad Sci U S A; 2013 May; 110(22):9025-30. PubMed ID: 23671066
[TBL] [Abstract][Full Text] [Related]
7. Tomography of epidermal growth factor receptor binding to fluorescent Affibody in vivo studied with magnetic resonance guided fluorescence recovery in varying orthotopic glioma sizes.
Holt RW; Demers JL; Sexton KJ; Gunn JR; Davis SC; Samkoe KS; Pogue BW
J Biomed Opt; 2015 Feb; 20(2):26001. PubMed ID: 25652703
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection.
Li L; Du Y; Chen X; Tian J
Mol Imaging Biol; 2018 Dec; 20(6):930-939. PubMed ID: 29651576
[TBL] [Abstract][Full Text] [Related]
9. Accounting for pharmacokinetic differences in dual-tracer receptor density imaging.
Tichauer KM; Diop M; Elliott JT; Samkoe KS; Hasan T; St Lawrence K; Pogue BW
Phys Med Biol; 2014 May; 59(10):2341-51. PubMed ID: 24743262
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Kinetic Models for Dual-Tracer Receptor Concentration Imaging in Tumors.
Hamzei N; Samkoe KS; Elliott JT; Holt RW; Gunn JR; Hasan T; Pogue BW; Tichauer KM
Austin J Biomed Eng; 2014 Mar; 1(1):. PubMed ID: 25414912
[TBL] [Abstract][Full Text] [Related]
11. Optical molecular imaging-guided radiation therapy part 2: Integrated x-ray and fluorescence molecular tomography.
Shi J; Udayakumar TS; Wang Z; Dogan N; Pollack A; Yang Y
Med Phys; 2017 Sep; 44(9):4795-4803. PubMed ID: 28626876
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Accuracy of FMT/CT and PET/MRI for the Assessment of Antibody Biodistribution in Squamous Cell Carcinoma Xenografts.
Hage C; Gremse F; Griessinger CM; Maurer A; Hoffmann SHL; Osl F; Pichler BJ; Kiessling F; Scheuer W; Pöschinger T
J Nucl Med; 2018 Jan; 59(1):44-50. PubMed ID: 28848038
[TBL] [Abstract][Full Text] [Related]
13. Targeting CAIX with [
Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.
Folaron M; Strawbridge R; Samkoe KS; Filan C; Roberts DW; Davis SC
J Neurosurg; 2018 Sep; 131(3):724-734. PubMed ID: 30192200
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous
Elliott JT; Marra K; Evans LT; Davis SC; Samkoe KS; Feldwisch J; Paulsen KD; Roberts DW; Pogue BW
Clin Cancer Res; 2017 May; 23(9):2203-2212. PubMed ID: 27799250
[No Abstract] [Full Text] [Related]
17. Quantifying cancer cell receptors with paired-agent fluorescent imaging: a novel method to account for tissue optical property effects.
Sadeghipour N; Davis SC; Tichauer KM
Proc SPIE Int Soc Opt Eng; 2018; 10497():. PubMed ID: 30220772
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors.
Abourbeh G; Dissoki S; Jacobson O; Litchi A; Ben Daniel R; Laki D; Levitzki A; Mishani E
Nucl Med Biol; 2007 Jan; 34(1):55-70. PubMed ID: 17210462
[TBL] [Abstract][Full Text] [Related]
19. Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct.
Nahrendorf M; Sosnovik DE; Waterman P; Swirski FK; Pande AN; Aikawa E; Figueiredo JL; Pittet MJ; Weissleder R
Circ Res; 2007 Apr; 100(8):1218-25. PubMed ID: 17379832
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma.
Tang J; Huang N; Zhang X; Zhou T; Tan Y; Pi J; Pi L; Cheng S; Zheng H; Cheng Y
Int J Nanomedicine; 2017; 12():3899-3911. PubMed ID: 28579776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
